Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy

A Primikyri, N Sayyad, G Quilici, EI Vrettos, K Lim, SW Chi, G Musco, IP Gerothanassis, AG Tzakos

Research output: Contribution to journalArticle

Abstract

In-cell NMR spectroscopy has emerged as a powerful technique for monitoring biomolecular interactions at an atomic level inside intact cells. However, current methodologies are inadequate at charting intracellular interactions of nonlabeled proteins and require their prior isotopic labeling. Herein, we describe for the first time the monitoring of the quercetin-alanine bioconjugate interaction with the nonlabeled antiapoptotic protein Bcl-2 inside living human cancer cells. STD and Tr-NOESY in-cell NMR methodologies were successfully applied in the investigation of the binding, which was further validated in vitro. In-cell NMR proved a very promising strategy for the real-time probing of the interaction profile of potential drugs with their therapeutic targets in native cellular environments and could, thus, open a new avenue in drug discovery. © 2018 Federation of European Biochemical Societies
Original languageEnglish
Pages (from-to)3367-3379
Number of pages13
JournalFEBS Letters
Volume592
Issue number20
DOIs
Publication statusPublished - 2018

Fingerprint

Quercetin
Nuclear magnetic resonance spectroscopy
Magnetic Resonance Spectroscopy
Cells
Nuclear magnetic resonance
Monitoring
Alanine
Labeling
Neoplasms
Proteins
Pharmaceutical Preparations
Drug Discovery
Sexually Transmitted Diseases

Cite this

Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy. / Primikyri, A; Sayyad, N; Quilici, G; Vrettos, EI; Lim, K; Chi, SW; Musco, G; Gerothanassis, IP; Tzakos, AG.

In: FEBS Letters, Vol. 592, No. 20, 2018, p. 3367-3379.

Research output: Contribution to journalArticle

Primikyri, A, Sayyad, N, Quilici, G, Vrettos, EI, Lim, K, Chi, SW, Musco, G, Gerothanassis, IP & Tzakos, AG 2018, 'Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy', FEBS Letters, vol. 592, no. 20, pp. 3367-3379. https://doi.org/10.1002/1873-3468.13250
Primikyri, A ; Sayyad, N ; Quilici, G ; Vrettos, EI ; Lim, K ; Chi, SW ; Musco, G ; Gerothanassis, IP ; Tzakos, AG. / Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy. In: FEBS Letters. 2018 ; Vol. 592, No. 20. pp. 3367-3379.
@article{95892e891f65466f90d94c12addebbf8,
title = "Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy",
abstract = "In-cell NMR spectroscopy has emerged as a powerful technique for monitoring biomolecular interactions at an atomic level inside intact cells. However, current methodologies are inadequate at charting intracellular interactions of nonlabeled proteins and require their prior isotopic labeling. Herein, we describe for the first time the monitoring of the quercetin-alanine bioconjugate interaction with the nonlabeled antiapoptotic protein Bcl-2 inside living human cancer cells. STD and Tr-NOESY in-cell NMR methodologies were successfully applied in the investigation of the binding, which was further validated in vitro. In-cell NMR proved a very promising strategy for the real-time probing of the interaction profile of potential drugs with their therapeutic targets in native cellular environments and could, thus, open a new avenue in drug discovery. {\circledC} 2018 Federation of European Biochemical Societies",
author = "A Primikyri and N Sayyad and G Quilici and EI Vrettos and K Lim and SW Chi and G Musco and IP Gerothanassis and AG Tzakos",
year = "2018",
doi = "10.1002/1873-3468.13250",
language = "English",
volume = "592",
pages = "3367--3379",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "20",

}

TY - JOUR

T1 - Probing the interaction of a quercetin bioconjugate with Bcl-2 in living human cancer cells with in-cell NMR spectroscopy

AU - Primikyri, A

AU - Sayyad, N

AU - Quilici, G

AU - Vrettos, EI

AU - Lim, K

AU - Chi, SW

AU - Musco, G

AU - Gerothanassis, IP

AU - Tzakos, AG

PY - 2018

Y1 - 2018

N2 - In-cell NMR spectroscopy has emerged as a powerful technique for monitoring biomolecular interactions at an atomic level inside intact cells. However, current methodologies are inadequate at charting intracellular interactions of nonlabeled proteins and require their prior isotopic labeling. Herein, we describe for the first time the monitoring of the quercetin-alanine bioconjugate interaction with the nonlabeled antiapoptotic protein Bcl-2 inside living human cancer cells. STD and Tr-NOESY in-cell NMR methodologies were successfully applied in the investigation of the binding, which was further validated in vitro. In-cell NMR proved a very promising strategy for the real-time probing of the interaction profile of potential drugs with their therapeutic targets in native cellular environments and could, thus, open a new avenue in drug discovery. © 2018 Federation of European Biochemical Societies

AB - In-cell NMR spectroscopy has emerged as a powerful technique for monitoring biomolecular interactions at an atomic level inside intact cells. However, current methodologies are inadequate at charting intracellular interactions of nonlabeled proteins and require their prior isotopic labeling. Herein, we describe for the first time the monitoring of the quercetin-alanine bioconjugate interaction with the nonlabeled antiapoptotic protein Bcl-2 inside living human cancer cells. STD and Tr-NOESY in-cell NMR methodologies were successfully applied in the investigation of the binding, which was further validated in vitro. In-cell NMR proved a very promising strategy for the real-time probing of the interaction profile of potential drugs with their therapeutic targets in native cellular environments and could, thus, open a new avenue in drug discovery. © 2018 Federation of European Biochemical Societies

U2 - 10.1002/1873-3468.13250

DO - 10.1002/1873-3468.13250

M3 - Article

VL - 592

SP - 3367

EP - 3379

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 20

ER -